Safety and efficacy of an extended-release peptide YY analogue for obesity: a randomized, placebo-controlled, phase 1 trial
While Semaglutide GLP-1 is generally well-tolerated by most patients, it does have potential side effects, including nausea, vomiting, abdominal pain, and diarrhea
Despite the availability of various treatments, lack or loss of response, intolerability, nontreatment, and undertreatment of patients with psoriatic disease or IBD, coupled with the high disease burden experienced by patients, remain a substantial problem [47, 48]
Semaglutide: Which is Better for PCOS
Manan Vora Big step forward with Semaglutide becoming more affordable in India, but honestly the risk of people using it without proper medical guidance is what worries me
Physiology, Menstrual Cycle